BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 489573)

  • 1. Membrane microenvironmental changes during activation of human blood platelets by thrombin. A study with a fluorescent probe.
    Nathan I; Fleischer G; Livne A; Dvilansky A; Parola AH
    J Biol Chem; 1979 Oct; 254(19):9822-8. PubMed ID: 489573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane dynamic alterations associated with activation of human platelets by thrombin.
    Nathan I; Fleisher G; Dvilansky A; Livne A; Parola AH
    Biochim Biophys Acta; 1980 May; 598(2):417-21. PubMed ID: 6769485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular viscosity changes during activation of blood platelets: studies by fluorescence polarization.
    Rotman A; Heldman J
    Biochemistry; 1981 Oct; 20(21):5995-9. PubMed ID: 7306488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parallel investigation of exocytosis kinetics and membrane fluidity changes in human platelets with the fluorescent probe, trimethylammonio-diphenylhexatriene.
    Kubina M; Lanza F; Cazenave JP; Laustriat G; Kuhry JG
    Biochim Biophys Acta; 1987 Jul; 901(1):138-46. PubMed ID: 3593721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet membrane potential: simultaneous measurement of diSC3(5) fluorescence and optical density.
    Pipili E
    Thromb Haemost; 1985 Oct; 54(3):645-9. PubMed ID: 2418525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin.
    Connolly TM; Limbird LE
    Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5320-4. PubMed ID: 6577431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epinephrine potentiates human platelet activation but is not an aggregating agent.
    Lanza F; Beretz A; Stierlé A; Hanau D; Kubina M; Cazenave JP
    Am J Physiol; 1988 Dec; 255(6 Pt 2):H1276-88. PubMed ID: 3202191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane changes associated with platelet activation. Exposure of actin on the platelet surface after thrombin-induced secretion.
    George JN; Lyons RM; Morgan RK
    J Clin Invest; 1980 Jul; 66(1):1-9. PubMed ID: 6772667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Function of intracellular [Ca2+]i in exocytosis and transbilayer movement in human platelets surface-labeled with the fluorescent probe 1-(4-trimethylammonio)phenyl)-6-phenyl-1,3,5-hexatriene.
    Heemskerk JW; Feijge MA; Andree HA; Sage SO
    Biochim Biophys Acta; 1993 Apr; 1147(2):194-204. PubMed ID: 8476913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence anisotropy changes in platelet membranes during activation.
    Steiner M; Lüscher EF
    Biochemistry; 1984 Jan; 23(2):247-52. PubMed ID: 6421313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of dietary fatty acids on membrane fluidity and activation of rat platelets.
    Heemskerk JW; Feijge MA; Kalafusz R; Hornstra G
    Biochim Biophys Acta; 1989 Aug; 1004(2):252-60. PubMed ID: 2752022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bidirectional transbilayer lipid movement in human platelets as vizualized by the fluorescent membrane probe 1-[4-(trimethylammonio)phenyl]-6-phenyl-1,3,5-hexatriene.
    Bevers EM; Verhallen PF; Visser AJ; Comfurius P; Zwaal RF
    Biochemistry; 1990 May; 29(21):5132-7. PubMed ID: 2378868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of human blood platelets with the 2',3'-dialdehyde and 2',3'-dialcohol derivatives of adenosine 5'-diphosphate and adenosine 5'-triphosphate.
    Pearce PH; Wright JM; Egan CM; Scrutton MC
    Eur J Biochem; 1978 Aug; 88(2):543-54. PubMed ID: 689037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
    Brammer JP; Maguire MH
    Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin-induced platelet aggregation involves an indirect proteolytic cleavage of aggregin by calpain.
    Puri RN; Zhou FX; Bradford H; Hu CJ; Colman RF; Colman RW
    Arch Biochem Biophys; 1989 Jun; 271(2):346-58. PubMed ID: 2543293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A platelet membrane protein expressed during platelet activation and secretion. Studies using a monoclonal antibody specific for thrombin-activated platelets.
    Hsu-Lin S; Berman CL; Furie BC; August D; Furie B
    J Biol Chem; 1984 Jul; 259(14):9121-6. PubMed ID: 6746643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of membrane anisotropy with function in subpopulations of human blood platelets.
    Raha S; Opper C; Wesemann W
    Br J Haematol; 1989 Jul; 72(3):397-401. PubMed ID: 2548563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet activation by 2-(4-bromo-2,3-dioxobutylthio)adenosine 5'-diphosphate is mediated by its binding to a putative ADP receptor, aggregin.
    Puri RN; Colman RF; Colman RW
    Eur J Biochem; 1996 Mar; 236(3):862-70. PubMed ID: 8665907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ca+2 mobilization and fibrinogen binding of platelets refractory to adenosine diphosphate stimulation.
    Peerschke EI
    J Lab Clin Med; 1985 Aug; 106(2):111-22. PubMed ID: 2991399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet activation studied by fluorescence polarization.
    Steiner M; Lüscher EF
    Biochim Biophys Acta; 1984 Feb; 803(1-2):48-53. PubMed ID: 6421332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.